Accelerate Diagnostics
AXDX
AXDX was delisted on the 14th of May, 2025.
52 hedge funds and large institutions have $104M invested in Accelerate Diagnostics in 2013 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 7 reducing their positions, and 6 closing their positions.
243% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 7
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
11% more funds holding
Funds holding: 47 → 52 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less capital invested
Capital invested by funds: $106M → $104M (-$2.15M)
24% less call options, than puts
Call options by funds: $262K | Put options by funds: $346K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$4.36M |
| 2 |
HCS
Harvest Capital Strategies
San Francisco,
California
|
+$1.6M |
| 3 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$1.26M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.09M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$986K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$5.44M |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$266K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$149K |
| 4 |
AFG
Albion Financial Group
Salt Lake City,
Utah
|
-$89.6K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$67.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WA
51
WFG Advisors
Dallas,
Texas
| $1K | – | – | – |
|
52
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $118 | +$114K | +852 | +704% |
|
|
53
Invesco
Atlanta,
Georgia
| – | -$5.44M | -40,554 | Closed |
|
|
BCM
54
Bridgeway Capital Management
Houston,
Texas
| – | -$266K | -1,980 | Closed |
|
|
RFC
55
Russell Frank Company
Seattle,
Washington
| – | -$34K | -306 | Closed |
|
56
Ameriprise
Minneapolis,
Minnesota
| – | -$9K | -65 | Closed |
|
57
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$7K | -51 | Closed |
|
58
Creative Planning
Overland Park,
Kansas
| – | -$1K | -10 | Closed |
|
AXDX Hedge Fund Activity: Q4 2013 in Review
52 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q4 2013, worth a combined $104M — down 2% from $106M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new AXDX positions and 6 closed out — a net gain of 5 holders — while 24 added to existing stakes and 7 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $4.36M. The largest seller was Invesco, exiting entirely with an estimated $5.44M sold.
- 52 institutional investors held Accelerate Diagnostics (AXDX) as of Q4 2013, up from 47 in Q3 2013.
- Funds reported $104M of Accelerate Diagnostics stock for Q4 2013, down 2% quarter-over-quarter.
- 11 funds opened new Accelerate Diagnostics positions in Q4 2013 and 6 closed out, a net change of +5 holders.
- The largest Accelerate Diagnostics buyer in Q4 2013 was Goldman Sachs, an estimated $4.36M added.
- The largest Accelerate Diagnostics seller in Q4 2013 was Invesco, an estimated $5.44M sold.
Based on aggregated 13F filings for Q4 2013.